Global Oligosaccharides in Infant Nutrition Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Source;

Bacteria, Plants, Algae, and Fungi.

By Type;

Galactoligosaccharides, Human Milk Oligosaccharides, and Fructooligosaccharides.

By Form;

Liquid and Powder.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn232477303 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Oligosaccharides in Infant Nutrition Market (USD Million), 2021 - 2031

In the year 2024, the Global Oligosaccharides in Infant Nutrition Market was valued at USD 2298.48 million. The size of this market is expected to increase to USD 4479.09 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 10.0%.

The global oligosaccharides in infant nutrition market has been experiencing steady growth, driven by an increasing demand for advanced and nutritious baby food products. Oligosaccharides, prebiotic carbohydrates that promote the growth of beneficial gut bacteria, play a critical role in infant nutrition, particularly in formula milk. These functional ingredients are considered essential for improving the digestive health and immune systems of infants, mimicking the natural benefits of breast milk. As a result, oligosaccharides are gaining traction as a key component in infant formula, making their way into the product formulations of major baby food manufacturers.

The growing awareness among parents about the importance of gut health and immunity for infants is further contributing to the market's expansion. With advancements in scientific research, manufacturers are increasingly focusing on incorporating oligosaccharides such as galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS) into infant nutrition products. These prebiotics are being utilized to replicate the prebiotic effects found in human milk, which is known to support the development of a healthy gut microbiota. This has led to the incorporation of oligosaccharides in both standard and specialized infant formulas, especially those designed for infants with specific dietary needs or health conditions.

In addition, the rise in disposable income, increasing awareness of the benefits of premium infant products, and the growing trend of working parents globally are all influencing the demand for convenient and high-quality infant nutrition solutions. The market is also witnessing a shift towards more organic and natural ingredient-based formulations, as parents are becoming more conscious of the ingredients used in baby food. This has encouraged manufacturers to innovate and develop new oligosaccharide-based products to meet the evolving needs of both parents and infants, driving further market growth in the sector.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Source
    2. Market Snapshot, By Type
    3. Market Snapshot, By Form
    4. Market Snapshot, By Region
  4. Global Oligosaccharides in Infant Nutrition Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing demand for infant nutrition with functional ingredients
        2. Rising awareness of gut health and immunity in infants
        3. Technological advancements in oligosaccharide extraction and application
        4. Growth of working parents and preference for convenience in baby food
      2. Restraints
        1. High cost of oligosaccharide-based ingredients
        2. Stringent regulations and quality control standards
        3. Limited availability of raw materials
        4. Potential allergic reactions or sensitivities in some infants
      3. Opportunities
        1. Development of organic and natural oligosaccharide-based formulas
        2. Expanding market in emerging economies with rising disposable income
        3. Introduction of innovative prebiotic-rich baby foods
        4. Increased focus on personalized nutrition for infants with specific needs
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Oligosaccharides in Infant Nutrition Market, By Source, 2021 - 2031 (USD Million)
      1. Bacteria
      2. Plants
      3. Algae
      4. Fungi
    2. Global Oligosaccharides in Infant Nutrition Market, By Type, 2021 - 2031(USD Million)
      1. Galactoligosaccharides
      2. Human Milk Oligosaccharides
      3. Fructooligosaccharides
    3. Global Oligosaccharides in Infant Nutrition Market, By Form, 2021- 2031 (USD Million)
      1. Liquid
      2. Powder
    4. Global Oligosaccharides in Infant Nutrition Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Ajinomoto
      2. CP Kelco
      3. Ingredion
      4. Tate & Lyle
      5. Bioriginal Food & Science Corporation
      6. Niacet
      7. Zhejiang Xinchang Haizhi Biotechnology
      8. AB Enzymes
      9. Royal DSM
      10. Cargill
      11. Kerry Group
      12. Biotec
      13. Glucan Corp.
      14. ProvidentBio
      15. Beta Glucan Innovations
  7. Analyst Views
  8. Future Outlook of the Market